The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis

A Sheh, JG Fox - Gut microbes, 2013 - Taylor & Francis
The discovery of Helicobacter pylori overturned the conventional dogma that the stomach
was a sterile organ and that pH values< 4 were capable of sterilizing the stomach. H. pylori …

Stem cells marked by the R-spondin receptor LGR5

BK Koo, H Clevers - Gastroenterology, 2014 - Elsevier
Since the discovery of LGR5 as a marker of intestinal stem cells, the field has developed
explosively and led to many new avenues of research. The inner workings of the intestinal …

[PDF][PDF] Basal and postprandial plasma levels of Pyy, Ghrelin

K Zwirska-Korczala, S Konturek, M Sodowski… - J Physiol …, 2007 - jpp.krakow.pl
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2007, 58, Suppl 1, 13 35 www. jpp.
krakow. pl postprandially in both OB-MS and MOB-MS, it was much lower than in lean …

Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms

MC Mommersteeg, J Yu, MP Peppelenbosch… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Helicobacter Pylori is a gram negative rod shaped microaerophilic bacterium that colonizes
the stomach of approximately half the world's population. Infection with c may cause chronic …

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with …

K Haruma, Y Kinoshita, T Yao, R Kushima… - BMC …, 2023 - Springer
Background VISION is a randomised, phase 4, open-label, parallel-group, multicentre study
conducted in 33 centres in Japan. The aim of this study was to assess the long-term safety of …

Gastrin—active participant or bystander in gastric carcinogenesis?

SA Watson, AM Grabowska, M El-Zaatari… - Nature Reviews …, 2006 - nature.com
Gastrin is a pro-proliferative, anti-apoptotic hormone with a central role in acid secretion in
the gastric mucosa and a long-standing association with malignant progression in …

Acid suppression therapy: where do we go from here?

C Scarpignato, I Pelosini, F Di Mario - Digestive Diseases, 2006 - karger.com
The dramatic success of pharmacological acid suppression in healing peptic ulcers and
managing patients with gastroesophageal reflux disease (GERD) has been reflected in the …

[HTML][HTML] Gastrin and gastric cancer

JP Smith, S Nadella, N Osborne - Cellular and molecular gastroenterology …, 2017 - Elsevier
Gastric cancer is the third leading cause of cancer-related mortality worldwide. Despite
progress in understanding its development, challenges with treatment remain. Gastrin, a …

Proton pump inhibitors and cancer risk: an umbrella review and meta-analysis of observational studies

ML Zhang, YX Fan, R Meng, WK Cai… - American Journal of …, 2022 - journals.lww.com
Objectives: Increasing evidence suggested that proton pump inhibitors (PPIs) use might
affect the development of cancers, but previous conclusions remain controversial. Therefore …

Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases

MJ Berna, RT Jensen - Current topics in medicinal chemistry, 2007 - ingentaconnect.com
In this paper, the estabished and possible roles of CCK1 and CCK2 receptors in
gastrointestinal (GI) and metabolic diseases are reviewed and available results from human …